首页> 外文期刊>Clinical Biochemistry >Multiplex PCR for detection of respiratory viruses: Can the laboratory performing a respiratory viral panel (RVP) assay trigger better patient care and clinical outcomes?
【24h】

Multiplex PCR for detection of respiratory viruses: Can the laboratory performing a respiratory viral panel (RVP) assay trigger better patient care and clinical outcomes?

机译:多重PCR检测呼吸道病毒:执行呼吸道病毒检测(RVP)分析的实验室能否触发更好的患者护理和临床结果?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Acute respiratory infection (ARI) is a leading cause of hospital-ization and acute care visits for infants and children, with the majority of patients being under 3 years of age. Most of these illnesses are due to viruses but concern about concurrent bacterial infections, results in excessive testing, overuse of antibiotics, and increased length of stay. Because different viral pathogens circulate simultaneously, viral epidemiology can vary from season to season, and clinical signs and symptoms are overlapping, a specific viral diagnosis cannot be made based on clinical presentation alone, thus resulting in overuse of antiviral medications as well. Fig. 1 depicts the virus etiologies during the peak weeks of the pandemic influenza AH1N1 (pH1N1) outbreak in the Hasbro Pediatric Hospital, where more than 50% of patients admitted for ARI with influenza-like symptoms had a virus other than pH1N1 identified. Molecular diagnostic tools now exist that allow detection of a large number of viruses simultaneously, termed respiratory virus panel (RVP) assays. In addition, RVP assays allow detection of viruses uncommonly evaluated for (such as rhinovirus and metapneumo-virus) with classical virologic methods including culture, direct fluorescent staining, and/or immunochromatographic techniques. Data from large clinical trials and review of literature using molecular RVP testing suggest that a molecular approach and provision of a specific viral diagnosis may be of benefit clinically as well as be cost-effective despite molecular's relatively high price tag compared to other test modalities. Data are beginning to accumulate that show that molecular testing for viral pathogens can lend to appropriate antiviral use, optimize infection control, limit antibiotics, reduce hospital stay, and help in identifying patients with the greatest risk for sequelae and severity of disease. In addition, assessing for many viruses provides ongoing information of viral epidemiology. In contras...
机译:急性呼吸道感染(ARI)是婴儿和儿童住院和进行急诊就诊的主要原因,大多数患者不到3岁。这些疾病大多数是由于病毒引起的,但担心并发细菌感染,过度检测,过度使用抗生素以及住院时间延长。由于不同的病毒病原体同时传播,病毒的流行病学因季节而异,并且临床体征和症状重叠,因此不能仅根据临床表现做出具体的病毒诊断,从而导致抗病毒药物的过度使用。图1描述了在孩之宝儿科医院大流行性流感AH1N1(pH1N1)爆发高峰周期间的病毒病因,其中50%以上因流感样症状而接受ARI入院的患者中发现的病毒不是pH1N1。现在,存在可以同时检测大量病毒的分子诊断工具,称为呼吸道病毒检测(RVP)分析。此外,RVP分析允许使用经典的病毒学方法(包括培养,直接荧光染色和/或免疫色谱技术)检测未经评估的病毒(例如鼻病毒和间质肺病毒)。来自大型临床试验的数据以及使用分子RVP测试的文献综述表明,尽管分子与其他测试方法相比价格相对较高,但分子方法和特定病毒诊断的提供可能在临床上有益并且具有成本效益。越来越多的数据表明,病毒病原体的分子检测可以适当地使用抗病毒药物,优化感染控制,限制抗生素使用,减少住院时间,并有助于确定罹患后遗症和疾病严重程度最高的患者。此外,评估许多病毒可提供病毒流行病学的持续信息。相反...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号